MedTrace Logo

Development and Validation of a Survival Prediction Model for Esophageal Cancer Patients After Esophagectomy

NCT06169930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2957

Last updated 2023-12-14

No results posted yet for this study

Summary

In this retrospective study, we analyzed data from the Sichuan Cancer Hospital \& Institute Esophageal Cancer Case Management Database (SCH-ECCM Database) from January 2010 to December 2017. Our study focused on examining the clinicopathological characteristics, lymph node removal at each station, and treatment details of patients with esophageal squamous cell carcinoma (ESCC) who underwent esophagectomy. Using this data, we developed a prediction model for OS by considering a combination of clinical characteristics and details of lymphadenectomy variables.

Conditions

  • Survivorship

Interventions

OTHER

This was an observational study without any intervention

This was an observational study without any intervention

Sponsors & Collaborators

  • Yongtao Han

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2023-12-01
Completion
2023-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06169930 on ClinicalTrials.gov